House Democrats had floated the possibility of funding drug research at the National Institutes of Health with savings from House Speaker Nancy Pelosi’s (D-CA) government drug price negotiation plan, but the committees of jurisdiction have so far decided to use the savings to expand Medicare benefits. Democrats had argued that funding NIH could ensure more innovation even if drug makers’ profits took a hit, but drug industry players said the research NIH and drug makers do is fundamentally different. Instead...